US Stock MarketDetailed Quotes

PCRX Pacira BioSciences

Watchlist
  • 19.860
  • +0.060+0.30%
Close Dec 13 16:00 ET
  • 19.860
  • 0.0000.00%
Post 16:20 ET
917.00MMarket Cap-10.03P/E (TTM)

Pacira BioSciences Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
21.34%53.92M
22.38%53.24M
156.70%49.1M
6.45%154.65M
13.20%47.58M
4.18%44.44M
45.94%43.5M
-37.85%19.13M
15.56%145.27M
81.08%42.04M
Net income from continuing operations
-1,421.29%-143.47M
-26.69%18.89M
145.96%8.98M
163.72%41.96M
346.19%24.87M
1,666.81%10.86M
29.62%25.76M
-386.12%-19.54M
-62.10%15.91M
-96.92%-10.1M
Operating gains losses
--0
----
----
--16.93M
--0
--0
--0
62,588.89%16.93M
----
----
Depreciation and amortization
9.87%20.25M
-1.00%18.86M
-6.00%18.43M
-17.41%75.57M
-39.21%18.49M
-8.74%18.43M
-8.68%19.05M
-2.15%19.6M
220.52%91.5M
132.64%30.41M
Deferred tax
-77.31%1.12M
9.55%12.54M
147.17%3.46M
296.54%15.62M
160.89%6.6M
600.00%4.91M
428.74%11.44M
-25,417.24%-7.34M
-173.08%-7.95M
-420.90%-10.84M
Other non cash items
-143.07%-2.54M
113.32%2.33M
-122.93%-3.03M
111.19%2.46M
121.19%854K
532.90%5.91M
11.14%-17.51M
1,522.48%13.21M
-205.97%-21.98M
-143.19%-4.03M
Change In working capital
125.46%2.09M
29.39%-4.39M
151.59%8.11M
-178.57%-45.78M
-608.93%-15.65M
-846.02%-8.2M
-19.06%-6.21M
-93.04%-15.72M
12.00%-16.43M
-835.17%-2.21M
-Change in receivables
94.39%4.13M
46.54%-3.14M
-24.56%3.92M
-244.35%-7.16M
-74.56%-8.6M
189.73%2.12M
-688.68%-5.88M
23.18%5.19M
80.07%-2.08M
63.52%-4.93M
-Change in inventory
-91.96%-8.43M
-885.95%-6.66M
145.37%7.57M
-433.47%-8.29M
-1,165.71%-7.83M
-215.86%-4.39M
-72.45%847K
160.37%3.09M
155.65%2.49M
138.54%735K
-Change in prepaid assets
-92.17%-5.03M
9.70%-2.21M
146.57%897K
-257.13%-9.64M
-24.50%-2.65M
-198.20%-2.62M
-337.88%-2.44M
54.79%-1.93M
-336.34%-2.7M
-1,006.81%-2.13M
-Change in payables and accrued expense
483.83%11.82M
444.02%7.64M
84.42%-3.51M
-55.49%-21.12M
-42.48%3.05M
39.60%-3.08M
113.09%1.4M
-635.99%-22.49M
-182.37%-13.59M
-59.43%5.29M
-Change in other current liabilities
-70.17%-405K
86.71%-19K
-283.14%-771K
178.06%434K
133.42%394K
-265.28%-238K
-134.96%-143K
501.43%421K
-434.62%-556K
-162.32%-1.18M
Cash from discontinued investing activities
Operating cash flow
21.34%53.92M
22.38%53.24M
156.70%49.1M
6.45%154.65M
13.20%47.58M
4.18%44.44M
45.94%43.5M
-37.85%19.13M
15.56%145.27M
81.08%42.04M
Investing cash flow
Cash flow from continuing investing activities
-1,101.36%-52.16M
-307.68%-15.22M
-123.47%-15.53M
134.43%77.54M
-25.16%8.37M
90.86%-4.34M
-61.77%7.33M
131.82%66.18M
-983.14%-225.19M
-83.28%11.19M
Net PPE purchase and sale
-20.57%-4.09M
53.29%-1.59M
56.80%-2.84M
49.59%-15.16M
67.26%-1.8M
34.49%-3.39M
70.99%-3.4M
14.38%-6.57M
34.43%-30.08M
40.08%-5.49M
Net business purchase and sale
----
----
----
--0
----
----
----
----
--0
----
Net investment purchase and sale
-4,970.78%-48.07M
-226.98%-13.63M
-117.45%-12.69M
156.83%92.7M
-39.02%10.17M
97.76%-948K
-65.27%10.73M
143.21%72.75M
-136.32%-163.11M
-96.66%16.68M
Net other investing changes
----
----
----
----
----
----
----
----
-700.00%-32M
--0
Cash from discontinued investing activities
Investing cash flow
-1,101.36%-52.16M
-307.68%-15.22M
-123.47%-15.53M
134.43%77.54M
-25.16%8.37M
90.86%-4.34M
-61.77%7.33M
131.82%66.18M
-983.14%-225.19M
-83.28%11.19M
Financing cash flow
Cash flow from continuing financing activities
89.76%-2.85M
5,577.27%24.98M
98.17%-2.82M
54.42%-183.03M
96.96%-1.78M
-257.39%-27.79M
100.29%440K
15.24%-153.91M
-205.47%-401.53M
-116.19%-58.51M
Net issuance payments of debt
89.89%-2.81M
3,123.57%85.05M
98.09%-2.81M
57.74%-180.76M
95.26%-2.81M
-196.66%-27.81M
98.31%-2.81M
23.51%-147.33M
-217.58%-427.69M
-116.32%-59.38M
Net common stock issuance
--0
----
----
----
----
--0
----
----
----
----
Proceeds from stock option exercised by employees
-106,936.00%-26.71M
-58.07%1.36M
--0
-82.63%4.75M
-44.14%1.14M
-98.44%25K
-74.34%3.25M
-96.98%333K
2.57%27.34M
-66.20%2.04M
Net other financing activities
--26.68M
---36.44M
99.94%-4K
-497.36%-7.02M
---106K
--0
--0
---6.91M
87.90%-1.18M
----
Cash from discontinued financing activities
Financing cash flow
89.76%-2.85M
5,577.27%24.98M
98.17%-2.82M
54.42%-183.03M
96.96%-1.78M
-257.39%-27.79M
100.29%440K
15.24%-153.91M
-205.47%-401.53M
-116.19%-58.51M
Net cash flow
Beginning cash position
184.59%247.05M
417.80%184.05M
47.21%153.3M
-82.22%104.14M
-9.42%99.12M
-28.88%86.81M
-84.32%35.55M
-82.22%104.14M
485.83%585.58M
-18.36%109.42M
Current changes in cash
-108.84%-1.09M
22.89%63M
144.83%30.75M
110.21%49.16M
1,125.15%54.18M
197.40%12.31M
148.97%51.27M
80.88%-68.59M
-199.14%-481.44M
-101.17%-5.29M
End cash Position
148.15%245.97M
184.59%247.05M
417.80%184.05M
47.21%153.3M
47.21%153.3M
-9.42%99.12M
-28.88%86.81M
-84.32%35.55M
-82.22%104.14M
-82.22%104.14M
Free cash flow
21.40%49.83M
28.81%51.65M
268.26%46.27M
21.09%139.49M
25.29%45.79M
9.53%41.04M
121.87%40.1M
-45.64%12.56M
44.27%115.2M
160.13%36.55M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 21.34%53.92M22.38%53.24M156.70%49.1M6.45%154.65M13.20%47.58M4.18%44.44M45.94%43.5M-37.85%19.13M15.56%145.27M81.08%42.04M
Net income from continuing operations -1,421.29%-143.47M-26.69%18.89M145.96%8.98M163.72%41.96M346.19%24.87M1,666.81%10.86M29.62%25.76M-386.12%-19.54M-62.10%15.91M-96.92%-10.1M
Operating gains losses --0----------16.93M--0--0--062,588.89%16.93M--------
Depreciation and amortization 9.87%20.25M-1.00%18.86M-6.00%18.43M-17.41%75.57M-39.21%18.49M-8.74%18.43M-8.68%19.05M-2.15%19.6M220.52%91.5M132.64%30.41M
Deferred tax -77.31%1.12M9.55%12.54M147.17%3.46M296.54%15.62M160.89%6.6M600.00%4.91M428.74%11.44M-25,417.24%-7.34M-173.08%-7.95M-420.90%-10.84M
Other non cash items -143.07%-2.54M113.32%2.33M-122.93%-3.03M111.19%2.46M121.19%854K532.90%5.91M11.14%-17.51M1,522.48%13.21M-205.97%-21.98M-143.19%-4.03M
Change In working capital 125.46%2.09M29.39%-4.39M151.59%8.11M-178.57%-45.78M-608.93%-15.65M-846.02%-8.2M-19.06%-6.21M-93.04%-15.72M12.00%-16.43M-835.17%-2.21M
-Change in receivables 94.39%4.13M46.54%-3.14M-24.56%3.92M-244.35%-7.16M-74.56%-8.6M189.73%2.12M-688.68%-5.88M23.18%5.19M80.07%-2.08M63.52%-4.93M
-Change in inventory -91.96%-8.43M-885.95%-6.66M145.37%7.57M-433.47%-8.29M-1,165.71%-7.83M-215.86%-4.39M-72.45%847K160.37%3.09M155.65%2.49M138.54%735K
-Change in prepaid assets -92.17%-5.03M9.70%-2.21M146.57%897K-257.13%-9.64M-24.50%-2.65M-198.20%-2.62M-337.88%-2.44M54.79%-1.93M-336.34%-2.7M-1,006.81%-2.13M
-Change in payables and accrued expense 483.83%11.82M444.02%7.64M84.42%-3.51M-55.49%-21.12M-42.48%3.05M39.60%-3.08M113.09%1.4M-635.99%-22.49M-182.37%-13.59M-59.43%5.29M
-Change in other current liabilities -70.17%-405K86.71%-19K-283.14%-771K178.06%434K133.42%394K-265.28%-238K-134.96%-143K501.43%421K-434.62%-556K-162.32%-1.18M
Cash from discontinued investing activities
Operating cash flow 21.34%53.92M22.38%53.24M156.70%49.1M6.45%154.65M13.20%47.58M4.18%44.44M45.94%43.5M-37.85%19.13M15.56%145.27M81.08%42.04M
Investing cash flow
Cash flow from continuing investing activities -1,101.36%-52.16M-307.68%-15.22M-123.47%-15.53M134.43%77.54M-25.16%8.37M90.86%-4.34M-61.77%7.33M131.82%66.18M-983.14%-225.19M-83.28%11.19M
Net PPE purchase and sale -20.57%-4.09M53.29%-1.59M56.80%-2.84M49.59%-15.16M67.26%-1.8M34.49%-3.39M70.99%-3.4M14.38%-6.57M34.43%-30.08M40.08%-5.49M
Net business purchase and sale --------------0------------------0----
Net investment purchase and sale -4,970.78%-48.07M-226.98%-13.63M-117.45%-12.69M156.83%92.7M-39.02%10.17M97.76%-948K-65.27%10.73M143.21%72.75M-136.32%-163.11M-96.66%16.68M
Net other investing changes ---------------------------------700.00%-32M--0
Cash from discontinued investing activities
Investing cash flow -1,101.36%-52.16M-307.68%-15.22M-123.47%-15.53M134.43%77.54M-25.16%8.37M90.86%-4.34M-61.77%7.33M131.82%66.18M-983.14%-225.19M-83.28%11.19M
Financing cash flow
Cash flow from continuing financing activities 89.76%-2.85M5,577.27%24.98M98.17%-2.82M54.42%-183.03M96.96%-1.78M-257.39%-27.79M100.29%440K15.24%-153.91M-205.47%-401.53M-116.19%-58.51M
Net issuance payments of debt 89.89%-2.81M3,123.57%85.05M98.09%-2.81M57.74%-180.76M95.26%-2.81M-196.66%-27.81M98.31%-2.81M23.51%-147.33M-217.58%-427.69M-116.32%-59.38M
Net common stock issuance --0------------------0----------------
Proceeds from stock option exercised by employees -106,936.00%-26.71M-58.07%1.36M--0-82.63%4.75M-44.14%1.14M-98.44%25K-74.34%3.25M-96.98%333K2.57%27.34M-66.20%2.04M
Net other financing activities --26.68M---36.44M99.94%-4K-497.36%-7.02M---106K--0--0---6.91M87.90%-1.18M----
Cash from discontinued financing activities
Financing cash flow 89.76%-2.85M5,577.27%24.98M98.17%-2.82M54.42%-183.03M96.96%-1.78M-257.39%-27.79M100.29%440K15.24%-153.91M-205.47%-401.53M-116.19%-58.51M
Net cash flow
Beginning cash position 184.59%247.05M417.80%184.05M47.21%153.3M-82.22%104.14M-9.42%99.12M-28.88%86.81M-84.32%35.55M-82.22%104.14M485.83%585.58M-18.36%109.42M
Current changes in cash -108.84%-1.09M22.89%63M144.83%30.75M110.21%49.16M1,125.15%54.18M197.40%12.31M148.97%51.27M80.88%-68.59M-199.14%-481.44M-101.17%-5.29M
End cash Position 148.15%245.97M184.59%247.05M417.80%184.05M47.21%153.3M47.21%153.3M-9.42%99.12M-28.88%86.81M-84.32%35.55M-82.22%104.14M-82.22%104.14M
Free cash flow 21.40%49.83M28.81%51.65M268.26%46.27M21.09%139.49M25.29%45.79M9.53%41.04M121.87%40.1M-45.64%12.56M44.27%115.2M160.13%36.55M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data